4 documents found, page 1 of 1
Analysis of the seroprevalence of and factors associated with Chagas disease in...
Freitas, Erlane Chaves; Oliveira, Maria de Fátima; Vasconcelos, Arduina Sofia Ortet de Barros; Silva Filho, José Damião daIntroduction: Chagas disease (CD) is currently considered a neglected disease; hence, identifying the factors associated with its high prevalence is essential. This study aimed to identify the seroprevalence of and the possible factors associated with CD in inhabitants of the City of Limoeiro do Norte, northeastern Brazil. Methods: Between April and November 2013, blood collection was conducted and a semi-struc...
Perfil hematológico e bioquímico de pacientes com doença de Chagas atendidos po...
Silva Filho, José Damião da; Costa, Alanna Carla; Freitas, Erlane Chaves; Viana, Carlos Eduardo Menezes; Lima, Monise Anne; Andrade, Mônica CoelhoIntroduction: Chagas’ disease (DC) is a parasite caused by the infectious agent Trypanosoma cruzi. In Brazil, the specific treatment of CD is performed with Benzonidazole (Bz), which due to its toxicity, can lead to the appearance of several adverse reactions to patients who use it. Therefore, there is a certain concern in evaluating the patient before starting the use of Bz, in order to verify possible hematol...
Inquérito soroepidemiológico da doença de Chagas no município de Limoeiro do No...
Freitas, Erlane ChavesChagas disease (CD) is considered neglected in many aspects, among them, for being a disease that affects people of low socioeconomic status, for the lack of investment in research to characterize the real picture of its prevalence and for the limited effectiveness of available drugs. The present study evaluated the seroprevalence of T. cruzi infection and the sociodemographic profile of people living in the ci...
Clinical and serological evolution in chronic Chagas disease patients in a 4-ye...
Andrade, Mônica Coelho; Oliveira, Maria de Fátima; Nagao-Dias, Aparecida Tiemi; Coêlho, Ivo Castelo Branco; Bezerra, Fernando Schemelzer MoraesIntroduction: The role of trypanocidal therapy in the chronic phase of Chagas disease remains controversial. Methods: A total of 13 patients with chronic Chagas disease were treated with benznidazole (5mg/kg/day/60 days) and surveyed via antibody measurement and conventional electrocardiogram over the course of 4 years. Results: The antibody titers were signifi cantly reduced after 4 years (p<0.05). Most of the...